Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade.
Bossio SN, Abrate C, Tosello Boari J, Rodriguez C, Canale FP, Ramello MC, Brunotto V, Richer W, Rocha D, Sedlik C, Vincent-Salomon A, Borcoman E, Del Castillo A, Gruppi A, Fernandez E, Acosta Rodríguez EV, Piaggio E, Montes CL. Bossio SN, et al. Oncoimmunology. 2023 Aug 18;12(1):2246319. doi: 10.1080/2162402X.2023.2246319. eCollection 2023. Oncoimmunology. 2023. PMID: 37885970 Free PMC article.
Centrosome amplification primes ovarian cancer cells for apoptosis and potentiates the response to chemotherapy.
Edwards F, Fantozzi G, Simon AY, Morretton JP, Herbette A, Tijhuis AE, Wardenaar R, Foulane S, Gemble S, Spierings DCJ, Foijer F, Mariani O, Vincent-Salomon A, Roman-Roman S, Sastre-Garau X, Goundiam O, Basto R. Edwards F, et al. Among authors: vincent salomon a. PLoS Biol. 2024 Sep 5;22(9):e3002759. doi: 10.1371/journal.pbio.3002759. eCollection 2024 Sep. PLoS Biol. 2024. PMID: 39236086 Free PMC article.
Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
Cyrta J, Brillet R, Laas E, Just PA, Andrianteranagna M, Leary A, Vincent-Salomon A, Bourdeaut F, Masliah-Planchon J. Cyrta J, et al. Among authors: vincent salomon a. Am J Surg Pathol. 2024 Oct 1;48(10):1335-1338. doi: 10.1097/PAS.0000000000002296. Epub 2024 Aug 2. Am J Surg Pathol. 2024. PMID: 39092991 Free PMC article. No abstract available.
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.
Villy MC, Le Ven A, Le Mentec M, Masliah-Planchon J, Houy A, Bièche I, Vacher S, Vincent-Salomon A, Dubois d'Enghien C, Schwartz M, Piperno-Neumann S, Matet A, Malaise D, Bubien V, Lortholary A, Ait Omar A, Cavaillé M, Stoppa-Lyonnet D, Cassoux N, Stern MH, Rodrigues M, Golmard L, Colas C. Villy MC, et al. J Natl Cancer Inst. 2024 Apr 5;116(4):580-587. doi: 10.1093/jnci/djad248. J Natl Cancer Inst. 2024. PMID: 38060262
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp.
Rodrigues M, Ramtohul T, Rampanou A, Sandoval JL, Houy A, Servois V, Mailly-Giacchetti L, Pierron G, Vincent-Salomon A, Cassoux N, Mariani P, Dutriaux C, Pracht M, Ryckewaert T, Kurtz JE, Roman-Roman S, Piperno-Neumann S, Bidard FC, Stern MH, Renault S. Rodrigues M, et al. Among authors: vincent salomon a. Nat Commun. 2024 Oct 14;15(1):8851. doi: 10.1038/s41467-024-53145-0. Nat Commun. 2024. PMID: 39402032 Free PMC article.
Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study.
Krishnamurthy S, Schnitt SJ, Vincent-Salomon A, Canas-Marques R, Colon E, Kantekure K, Maklakovski M, Finck W, Thomassin J, Globerson Y, Bien L, Mallel G, Grinwald M, Linhart C, Sandbank J, Vecsler M. Krishnamurthy S, et al. Among authors: vincent salomon a. JCO Precis Oncol. 2024 Oct;8:e2400353. doi: 10.1200/PO.24.00353. Epub 2024 Oct 11. JCO Precis Oncol. 2024. PMID: 39393036 Free PMC article.
Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.
Ramtohul T, Lepagney V, Bonneau C, Jin M, Menet E, Sauge J, Laas E, Romano E, Bello-Roufai D, Mechta-Grigoriou F, Vincent Salomon A, Bidard FC, Langer A, Malhaire C, Cabel L, Brisse HJ, Tardivon A. Ramtohul T, et al. Among authors: vincent salomon a. Radiology. 2024 Sep;312(3):e240575. doi: 10.1148/radiol.240575. Radiology. 2024. PMID: 39225608
442 results